Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABATACEPT Cause Intentional product use issue? 3,693 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 3,693 reports of Intentional product use issue have been filed in association with ABATACEPT (ORENCIA). This represents 3.2% of all adverse event reports for ABATACEPT.

3,693
Reports of Intentional product use issue with ABATACEPT
3.2%
of all ABATACEPT reports
1,146
Deaths
1,645
Hospitalizations

How Dangerous Is Intentional product use issue From ABATACEPT?

Of the 3,693 reports, 1,146 (31.0%) resulted in death, 1,645 (44.5%) required hospitalization, and 1,427 (38.6%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABATACEPT. However, 3,693 reports have been filed with the FAERS database.

What Other Side Effects Does ABATACEPT Cause?

Drug ineffective (35,212) Rheumatoid arthritis (21,898) Pain (19,783) Arthralgia (18,536) Joint swelling (18,453) Contraindicated product administered (13,559) Fatigue (13,087) Drug intolerance (12,451) Rash (12,168) Arthropathy (11,099)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280) HYDROXYCHLOROQUINE (3,059)

Which ABATACEPT Alternatives Have Lower Intentional product use issue Risk?

ABATACEPT vs ABATACEPT SUBQ /ML ABATACEPT vs ABCIXIMAB ABATACEPT vs ABEMACICLIB ABATACEPT vs ABILIFY ABATACEPT vs ABIRATERONE

Related Pages

ABATACEPT Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue ABATACEPT Demographics